Company Number: 13544375

Analysis Date: 2025-07-29 17:51 UTC

1. Risk Rating: LOW
   RLB Therapy Ltd exhibits a solid liquidity position with current assets comfortably exceeding current liabilities and positive net assets. The company is active, compliant with filing deadlines, and shows no signs of insolvency or liquidation.

2. Key Concerns:

• Modest Scale and Single Director: The company is micro-sized with only one employee and a single director/shareholder, creating dependency risk on one individual.
• Limited Financial Data Transparency: The accounts are unaudited and only filed under the small companies regime with limited disclosures, restricting comprehensive financial analysis.
• Declining Net Assets: Net assets have slightly decreased from £12,928 in 2023 to £11,709 in 2024, indicating a small erosion of equity that warrants monitoring over time.

3. Positive Indicators:

• Strong Liquidity: Cash balances are high relative to current liabilities (£14,420 cash vs. £4,374 current liabilities in 2024), supporting short-term solvency.
• Timely Compliance: No overdue filings for annual accounts or confirmation statement, suggesting good governance and regulatory adherence.
• Consistent Shareholder Funding: Shareholder funds remain positive and stable, with retained earnings over £11,000, demonstrating ongoing capital support.

4. Due Diligence Notes:

• Review detailed profit and loss figures (not publicly filed) to assess operational profitability and trends.
• Verify the nature and stability of income streams given the SIC code "Other human health activities" which may reflect a niche therapy service.
• Clarify provisions for liabilities (£348 in 2024) to understand contingent risks or future obligations.
• Assess director's reliance risk and any succession planning given sole control by Mrs. Blanchard.
• Confirm absence of any director disqualifications or legal issues through official records.